Chemicals
Showing 18451–18600 of 41137 results
-
Elagolix is an antagonist of the gonadotropin-releasing hormone receptor (GnRHR; Ki = 0.9 nM in a radioligand binding assay).{45161} It is selective for GnRHR over the cytochrome P450 (CYP) isoform CYP3A4 (IC50 = 56 μM) as well as a panel of 100 receptors, ion channels, enzymes, and transporters (IC50s = >10 μM). Elagolix inhibits GnRH-induced inositol phosphate production in RBL-1 cells expressing human GnRHR (IC50 = 1.5 nM). In vivo, elagolix (30 mg/kg) suppresses production of luteinizing hormone in castrated male cynomolgus macaques. Formulations containing elagolix have been used in the treatment of endometriosis.
Brand:CaymanSKU:26534 - 25 mgAvailable on backorder
Elagolix is an antagonist of the gonadotropin-releasing hormone receptor (GnRHR; Ki = 0.9 nM in a radioligand binding assay).{45161} It is selective for GnRHR over the cytochrome P450 (CYP) isoform CYP3A4 (IC50 = 56 μM) as well as a panel of 100 receptors, ion channels, enzymes, and transporters (IC50s = >10 μM). Elagolix inhibits GnRH-induced inositol phosphate production in RBL-1 cells expressing human GnRHR (IC50 = 1.5 nM). In vivo, elagolix (30 mg/kg) suppresses production of luteinizing hormone in castrated male cynomolgus macaques. Formulations containing elagolix have been used in the treatment of endometriosis.
Brand:CaymanSKU:26534 - 5 mgAvailable on backorder
Elaidamide is a fatty acid amide that has been found in the cerebrospinal fluid of sleep-deprived cats.{1317} It inhibits rat microsomal epoxide hydrolase (mEH; Ki = 70 nM).{50370} Elaidamide also inhibits porcine pancreatic and human synovial phospholipase A2 (PLA2).{50371} In vivo, elaidamide (10 mg/animal) induces physiological sleep in rats.{1317}
Brand:CaymanSKU:21079 -Out of stock
Elaidamide is a fatty acid amide that has been found in the cerebrospinal fluid of sleep-deprived cats.{1317} It inhibits rat microsomal epoxide hydrolase (mEH; Ki = 70 nM).{50370} Elaidamide also inhibits porcine pancreatic and human synovial phospholipase A2 (PLA2).{50371} In vivo, elaidamide (10 mg/animal) induces physiological sleep in rats.{1317}
Brand:CaymanSKU:21079 -Out of stock
Elaidamide is a fatty acid amide that has been found in the cerebrospinal fluid of sleep-deprived cats.{1317} It inhibits rat microsomal epoxide hydrolase (mEH; Ki = 70 nM).{50370} Elaidamide also inhibits porcine pancreatic and human synovial phospholipase A2 (PLA2).{50371} In vivo, elaidamide (10 mg/animal) induces physiological sleep in rats.{1317}
Brand:CaymanSKU:21079 -Out of stock
Elaidic acid is a monounsaturated trans fatty acid and the 9-trans isomer of oleic acid (Item Nos. 90260 | 24659) that has been found in partially hydrogenated cooking oils.{2046} It reduces HHT and HETE formation and increases synthesis of prostaglandin E2 (PGE2; Item No. 14010), PGF2α (Item Nos. 16010 | 16020), PGD2 (Item No. 12010), and thromboxane B2 (TXB2; Item No. 19030) induced by arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) in isolated human platelets. Elaidic acid (0.1-5 mmol/L) induces apoptosis in human umbilical vein endothelial cells (HUVECs).{57088} In vivo, elaidic acid (100 mg/kg) reduces cardiac and hepatic autophagy induced by palmitic acid (Item No. 10006627) in mice.{57089}
Brand:CaymanSKU:90250 - 1 gAvailable on backorder
Elaidic acid is a monounsaturated trans fatty acid and the 9-trans isomer of oleic acid (Item Nos. 90260 | 24659) that has been found in partially hydrogenated cooking oils.{2046} It reduces HHT and HETE formation and increases synthesis of prostaglandin E2 (PGE2; Item No. 14010), PGF2α (Item Nos. 16010 | 16020), PGD2 (Item No. 12010), and thromboxane B2 (TXB2; Item No. 19030) induced by arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) in isolated human platelets. Elaidic acid (0.1-5 mmol/L) induces apoptosis in human umbilical vein endothelial cells (HUVECs).{57088} In vivo, elaidic acid (100 mg/kg) reduces cardiac and hepatic autophagy induced by palmitic acid (Item No. 10006627) in mice.{57089}
Brand:CaymanSKU:90250 - 100 mgAvailable on backorder
Elaidic acid is a monounsaturated trans fatty acid and the 9-trans isomer of oleic acid (Item Nos. 90260 | 24659) that has been found in partially hydrogenated cooking oils.{2046} It reduces HHT and HETE formation and increases synthesis of prostaglandin E2 (PGE2; Item No. 14010), PGF2α (Item Nos. 16010 | 16020), PGD2 (Item No. 12010), and thromboxane B2 (TXB2; Item No. 19030) induced by arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) in isolated human platelets. Elaidic acid (0.1-5 mmol/L) induces apoptosis in human umbilical vein endothelial cells (HUVECs).{57088} In vivo, elaidic acid (100 mg/kg) reduces cardiac and hepatic autophagy induced by palmitic acid (Item No. 10006627) in mice.{57089}
Brand:CaymanSKU:90250 - 250 mgAvailable on backorder
Elaidic acid is a monounsaturated trans fatty acid and the 9-trans isomer of oleic acid (Item Nos. 90260 | 24659) that has been found in partially hydrogenated cooking oils.{2046} It reduces HHT and HETE formation and increases synthesis of prostaglandin E2 (PGE2; Item No. 14010), PGF2α (Item Nos. 16010 | 16020), PGD2 (Item No. 12010), and thromboxane B2 (TXB2; Item No. 19030) induced by arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) in isolated human platelets. Elaidic acid (0.1-5 mmol/L) induces apoptosis in human umbilical vein endothelial cells (HUVECs).{57088} In vivo, elaidic acid (100 mg/kg) reduces cardiac and hepatic autophagy induced by palmitic acid (Item No. 10006627) in mice.{57089}
Brand:CaymanSKU:90250 - 50 mgAvailable on backorder
Elaidic acid methyl ester is an esterified form of elaidic acid (Item No. 90250) that has been found in biodiesel produced by the microalga Botryococcus.{46213} It has also been found in Iranian olive fruit oil and certain cultivars of O. sativa black rice bran.{49105,49106}
Brand:CaymanSKU:26870 - 1 gAvailable on backorder
Elaidic acid methyl ester is an esterified form of elaidic acid (Item No. 90250) that has been found in biodiesel produced by the microalga Botryococcus.{46213} It has also been found in Iranian olive fruit oil and certain cultivars of O. sativa black rice bran.{49105,49106}
Brand:CaymanSKU:26870 - 500 mgAvailable on backorder
Elaidyl alcohol is a monounsaturated fatty alcohol produced by the hydrogenation of elaidic acid (Item No. 90250).{53908} It is active against herpes simplex virus 2 (HSV-2) and bacteriophage ϕ6, but not Pseudoalteromonas phage PM2, virions in plaque assays (IC50s = 1.9, 0.4, and >75 µM, respectively).{53909} Elaidyl alcohol has been used in the formation of bimolecular films to study the effect of unsaturation on model lipid membranes.{53910}
Brand:CaymanSKU:30459 - 1 gAvailable on backorder
Elaidyl alcohol is a monounsaturated fatty alcohol produced by the hydrogenation of elaidic acid (Item No. 90250).{53908} It is active against herpes simplex virus 2 (HSV-2) and bacteriophage ϕ6, but not Pseudoalteromonas phage PM2, virions in plaque assays (IC50s = 1.9, 0.4, and >75 µM, respectively).{53909} Elaidyl alcohol has been used in the formation of bimolecular films to study the effect of unsaturation on model lipid membranes.{53910}
Brand:CaymanSKU:30459 - 250 mgAvailable on backorder
Elaidyl alcohol is a monounsaturated fatty alcohol produced by the hydrogenation of elaidic acid (Item No. 90250).{53908} It is active against herpes simplex virus 2 (HSV-2) and bacteriophage ϕ6, but not Pseudoalteromonas phage PM2, virions in plaque assays (IC50s = 1.9, 0.4, and >75 µM, respectively).{53909} Elaidyl alcohol has been used in the formation of bimolecular films to study the effect of unsaturation on model lipid membranes.{53910}
Brand:CaymanSKU:30459 - 500 mgAvailable on backorder
Elaiophylin is a macrodiolide antibiotic that can be isolated from various strains of Streptomyces.{25429,25428} It displays in vitro anti-protozoal activity against both Plasmodium and Trypanosoma (IC50s = 370 and 460 ng/ml, respectively) and cytotoxicity against human fetal lung fibroblast MRC-5 cells (IC50 = 870 ng/ml).{25430} Elaiophylin alone has no activity against Candida, although it enhances the anti-fungal activity of rapamycin (Item No. 13346).{25428} Elaiophylin also forms stable, long-lasting ion channels in bilayer membranes that are selective for cations.{25431}
Brand:CaymanSKU:- Elaiophylin is a macrodiolide antibiotic that can be isolated from various strains of Streptomyces.{25429,25428} It displays in vitro anti-protozoal activity against both Plasmodium and Trypanosoma (IC50s = 370 and 460 ng/ml, respectively) and cytotoxicity against human fetal lung fibroblast MRC-5 cells (IC50 = 870 ng/ml).{25430} Elaiophylin alone has no activity against Candida, although it enhances the anti-fungal activity of rapamycin (Item No. 13346).{25428} Elaiophylin also forms stable, long-lasting ion channels in bilayer membranes that are selective for cations.{25431}
Brand:CaymanSKU:-
Elasnin is a product isolated from certain strains of Streptomyces that acts as a reversible inhibitor of elastase with IC50 values of 1.3 and 30 µg/ml for human granulocyte and pancreatic enzymes, respectively.{34289} It inhibits human leukocyte elastase, porcine pancreatic elastase, and chymotrypsin with Ki values of 93, 69, and 224 µM, respectively.{34290}
Brand:CaymanSKU:21481 -Out of stock
Elastatinal is a potent inhibitor of pancreatic elastase (Ki = 240 nM) that is produced by various species of Actinomycetes.{39141} It more strongly inhibits pancreatic elastase versus the leukocyte-derived enzyme.{39142,39143} Elastatinal reduces electrophoretic mobilities of 2A proteinases from poliovirus and human rhinovirus 14 in a dose-dependent manner, indicating substrate recognition by 2A proteinases is similar to that of pancreatic elastases.{39144} It can also inhibit elastase-like protease collagenolytic protease from C. maenas digestive glands.{39145}
Brand:CaymanSKU:22288 -Out of stock
Elastatinal is a potent inhibitor of pancreatic elastase (Ki = 240 nM) that is produced by various species of Actinomycetes.{39141} It more strongly inhibits pancreatic elastase versus the leukocyte-derived enzyme.{39142,39143} Elastatinal reduces electrophoretic mobilities of 2A proteinases from poliovirus and human rhinovirus 14 in a dose-dependent manner, indicating substrate recognition by 2A proteinases is similar to that of pancreatic elastases.{39144} It can also inhibit elastase-like protease collagenolytic protease from C. maenas digestive glands.{39145}
Brand:CaymanSKU:22288 -Out of stock
Elastatinal is a potent inhibitor of pancreatic elastase (Ki = 240 nM) that is produced by various species of Actinomycetes.{39141} It more strongly inhibits pancreatic elastase versus the leukocyte-derived enzyme.{39142,39143} Elastatinal reduces electrophoretic mobilities of 2A proteinases from poliovirus and human rhinovirus 14 in a dose-dependent manner, indicating substrate recognition by 2A proteinases is similar to that of pancreatic elastases.{39144} It can also inhibit elastase-like protease collagenolytic protease from C. maenas digestive glands.{39145}
Brand:CaymanSKU:22288 -Out of stock
Elbasvir is a direct-acting antiviral drug that potently inhibits hepatitis C virus (HCV) non-structural protein 5A (NS5A) with an EC50 value of 2.2 pM in Huh7 human liver cancer cells expressing pH77S.3/GLuc2A, a cell-culture adapted HCV16 genotype 1a derivative and luciferase reporter, following a 48-hour exposure in vitro.{37386,37388} NS5A is essential for HCV RNA synthesis and viral assembly, and elbasvir inhibits the assembly of new viral replicase complexes when used at a concentration of 50 pM.{37388} It exhibits potent inhibitory activity against a broad range of HCV genotypes with EC50 values of 0.0002-34 nM in Huh7 cells expressing replicons of HCV genotype 4 NS5A and EC50 values of less than 0.2 nM for replicons from all other tested genotypes except 2b.{37385,37386,37387} Formulations containing elbasvir have been used alone and in combination with NS3/4A protease inhibitors in the treatment of HCV.
Brand:CaymanSKU:24031 - 1 mgAvailable on backorder
Elbasvir is a direct-acting antiviral drug that potently inhibits hepatitis C virus (HCV) non-structural protein 5A (NS5A) with an EC50 value of 2.2 pM in Huh7 human liver cancer cells expressing pH77S.3/GLuc2A, a cell-culture adapted HCV16 genotype 1a derivative and luciferase reporter, following a 48-hour exposure in vitro.{37386,37388} NS5A is essential for HCV RNA synthesis and viral assembly, and elbasvir inhibits the assembly of new viral replicase complexes when used at a concentration of 50 pM.{37388} It exhibits potent inhibitory activity against a broad range of HCV genotypes with EC50 values of 0.0002-34 nM in Huh7 cells expressing replicons of HCV genotype 4 NS5A and EC50 values of less than 0.2 nM for replicons from all other tested genotypes except 2b.{37385,37386,37387} Formulations containing elbasvir have been used alone and in combination with NS3/4A protease inhibitors in the treatment of HCV.
Brand:CaymanSKU:24031 - 5 mgAvailable on backorder
Eledoisin is an undecapeptide tachykinin neuropeptide and neurokinin (NK) receptor agonist originally isolated from E. moschata.{46470,46472} It binds to NK1 (pD2 = 9.5 and 9.21 in isolated dog carotid artery and guinea pig ileum, respectively), NK2 (pD2 = 8.22 and 7.7 in isolated rabbit pulmonary artery and rat duodenum, respectively), and NK3 receptors (pD2 = 7.11 and 7.06 in isolated rat portal vein and hamster urinary bladder, respectively).{46471} Eledoisin induces contraction of isolated guinea pig ileum and rabbit jejunum.{41381} It also induces salivation in rats and lowers arterial blood pressure in rabbits and guinea pigs in vivo.{41381,46473}
Brand:CaymanSKU:28810 - 1 mgAvailable on backorder
Eledoisin is an undecapeptide tachykinin neuropeptide and neurokinin (NK) receptor agonist originally isolated from E. moschata.{46470,46472} It binds to NK1 (pD2 = 9.5 and 9.21 in isolated dog carotid artery and guinea pig ileum, respectively), NK2 (pD2 = 8.22 and 7.7 in isolated rabbit pulmonary artery and rat duodenum, respectively), and NK3 receptors (pD2 = 7.11 and 7.06 in isolated rat portal vein and hamster urinary bladder, respectively).{46471} Eledoisin induces contraction of isolated guinea pig ileum and rabbit jejunum.{41381} It also induces salivation in rats and lowers arterial blood pressure in rabbits and guinea pigs in vivo.{41381,46473}
Brand:CaymanSKU:28810 - 10 mgAvailable on backorder
Eledoisin is an undecapeptide tachykinin neuropeptide and neurokinin (NK) receptor agonist originally isolated from E. moschata.{46470,46472} It binds to NK1 (pD2 = 9.5 and 9.21 in isolated dog carotid artery and guinea pig ileum, respectively), NK2 (pD2 = 8.22 and 7.7 in isolated rabbit pulmonary artery and rat duodenum, respectively), and NK3 receptors (pD2 = 7.11 and 7.06 in isolated rat portal vein and hamster urinary bladder, respectively).{46471} Eledoisin induces contraction of isolated guinea pig ileum and rabbit jejunum.{41381} It also induces salivation in rats and lowers arterial blood pressure in rabbits and guinea pigs in vivo.{41381,46473}
Brand:CaymanSKU:28810 - 5 mgAvailable on backorder
Elemicin is a trioxygenated phenylpropane that has been found in A. dracunculus.{49622} It is active against S. aureus, B. subtilis, and C. albicans (MICs = 600, 2,500, and 1,000 mg/L, respectively) but not E. coli, K. pneumoniae, P. aeruginosa (MICs = >8,000 mg/L for all), or L. monocytogenes (MIC = >3,000 mg/L). Elemicin is toxic to mice following metabolic activation to 1’-hydroxyelemicin by the cytochrome P450 (CYP) isoforms CYP1A1 and CYP1A2.{49623} It increases plasma and hepatic triglyceride levels, decreases stearoyl-CoA desaturase 1 (Scd1) expression, and induces hepatomegaly in mice when administered at a dose of 500 mg/kg per day for three weeks.
Brand:CaymanSKU:29394 - 1 gAvailable on backorder
Elemicin is a trioxygenated phenylpropane that has been found in A. dracunculus.{49622} It is active against S. aureus, B. subtilis, and C. albicans (MICs = 600, 2,500, and 1,000 mg/L, respectively) but not E. coli, K. pneumoniae, P. aeruginosa (MICs = >8,000 mg/L for all), or L. monocytogenes (MIC = >3,000 mg/L). Elemicin is toxic to mice following metabolic activation to 1’-hydroxyelemicin by the cytochrome P450 (CYP) isoforms CYP1A1 and CYP1A2.{49623} It increases plasma and hepatic triglyceride levels, decreases stearoyl-CoA desaturase 1 (Scd1) expression, and induces hepatomegaly in mice when administered at a dose of 500 mg/kg per day for three weeks.
Brand:CaymanSKU:29394 - 250 mgAvailable on backorder
Elemicin is a trioxygenated phenylpropane that has been found in A. dracunculus.{49622} It is active against S. aureus, B. subtilis, and C. albicans (MICs = 600, 2,500, and 1,000 mg/L, respectively) but not E. coli, K. pneumoniae, P. aeruginosa (MICs = >8,000 mg/L for all), or L. monocytogenes (MIC = >3,000 mg/L). Elemicin is toxic to mice following metabolic activation to 1’-hydroxyelemicin by the cytochrome P450 (CYP) isoforms CYP1A1 and CYP1A2.{49623} It increases plasma and hepatic triglyceride levels, decreases stearoyl-CoA desaturase 1 (Scd1) expression, and induces hepatomegaly in mice when administered at a dose of 500 mg/kg per day for three weeks.
Brand:CaymanSKU:29394 - 500 mgAvailable on backorder
Eletriptan is an agonist of the serotonin (5-HT) receptor types 5-HT1B and 5-HT1D.{32188} It inhibits forskolin-induced cAMP accumulation in and induces vasoconstriction of isolated rabbit common carotid artery rings (pD2s = 7.6 and 4.9, respectively), an effect that can be blocked by the 5-HT1B antagonist SB216641 but not the 5-HT1D antagonist BRL15572. Eletriptan preferentially induces constriction of isolated human cerebral over coronary arteries (EC50s = 15.8 and 1,995 nM, respectively).{42283} Formulations containing eletriptan have been used in the treatment of migraine headache.
Brand:CaymanSKU:20048 -Available on backorder
Eletriptan is an agonist of the serotonin (5-HT) receptor types 5-HT1B and 5-HT1D.{32188} It inhibits forskolin-induced cAMP accumulation in and induces vasoconstriction of isolated rabbit common carotid artery rings (pD2s = 7.6 and 4.9, respectively), an effect that can be blocked by the 5-HT1B antagonist SB216641 but not the 5-HT1D antagonist BRL15572. Eletriptan preferentially induces constriction of isolated human cerebral over coronary arteries (EC50s = 15.8 and 1,995 nM, respectively).{42283} Formulations containing eletriptan have been used in the treatment of migraine headache.
Brand:CaymanSKU:20048 -Available on backorder
Eletriptan is an agonist of the serotonin (5-HT) receptor types 5-HT1B and 5-HT1D.{32188} It inhibits forskolin-induced cAMP accumulation in and induces vasoconstriction of isolated rabbit common carotid artery rings (pD2s = 7.6 and 4.9, respectively), an effect that can be blocked by the 5-HT1B antagonist SB216641 but not the 5-HT1D antagonist BRL15572. Eletriptan preferentially induces constriction of isolated human cerebral over coronary arteries (EC50s = 15.8 and 1,995 nM, respectively).{42283} Formulations containing eletriptan have been used in the treatment of migraine headache.
Brand:CaymanSKU:20048 -Available on backorder
Eletriptan is an agonist of the serotonin (5-HT) receptor types 5-HT1B and 5-HT1D.{32188} It inhibits forskolin-induced cAMP accumulation in and induces vasoconstriction of isolated rabbit common carotid artery rings (pD2s = 7.6 and 4.9, respectively), an effect that can be blocked by the 5-HT1B antagonist SB216641 but not the 5-HT1D antagonist BRL15572. Eletriptan preferentially induces constriction of isolated human cerebral over coronary arteries (EC50s = 15.8 and 1,995 nM, respectively).{42283} Formulations containing eletriptan have been used in the treatment of migraine headache.
Brand:CaymanSKU:20048 -Available on backorder
Eleutheroside E is a glycoside and major component of E. senticosus and has diverse biological activities.{46673} It protects against axonal and dendritic atrophies induced by amyloid-β (25-35) (Aβ (25-35); Item No. 24155) in primary rat cortical neurons.{46673,46675,46674,46676} Eleutheroside E (15, 30, and 60 mg/kg) reduces macrophage infiltration, pannus formation, cartilage damage, bone erosion, and the production of TNF-α and IL-6 in a mouse model of collagen-induced arthritis.{46675} It increases insulin sensitivity and reduces pancreatic α- and β-cell death in db/db diabetic mice.{46674} Eleutheroside E (10 and 50 mg/kg) increases the latency to enter the dark chamber in a passive avoidance test and the levels of glutathione (GSH) in the hippocampus and decreases errors in the Y-maze test and hippocampal malondialdehyde (MDA) levels in a mouse model of sleep deprivation-induced stress.{46676}
Brand:CaymanSKU:29684 - 100 mgAvailable on backorder
Eleutheroside E is a glycoside and major component of E. senticosus and has diverse biological activities.{46673} It protects against axonal and dendritic atrophies induced by amyloid-β (25-35) (Aβ (25-35); Item No. 24155) in primary rat cortical neurons.{46673,46675,46674,46676} Eleutheroside E (15, 30, and 60 mg/kg) reduces macrophage infiltration, pannus formation, cartilage damage, bone erosion, and the production of TNF-α and IL-6 in a mouse model of collagen-induced arthritis.{46675} It increases insulin sensitivity and reduces pancreatic α- and β-cell death in db/db diabetic mice.{46674} Eleutheroside E (10 and 50 mg/kg) increases the latency to enter the dark chamber in a passive avoidance test and the levels of glutathione (GSH) in the hippocampus and decreases errors in the Y-maze test and hippocampal malondialdehyde (MDA) levels in a mouse model of sleep deprivation-induced stress.{46676}
Brand:CaymanSKU:29684 - 250 mgAvailable on backorder
Eleutheroside E is a glycoside and major component of E. senticosus and has diverse biological activities.{46673} It protects against axonal and dendritic atrophies induced by amyloid-β (25-35) (Aβ (25-35); Item No. 24155) in primary rat cortical neurons.{46673,46675,46674,46676} Eleutheroside E (15, 30, and 60 mg/kg) reduces macrophage infiltration, pannus formation, cartilage damage, bone erosion, and the production of TNF-α and IL-6 in a mouse model of collagen-induced arthritis.{46675} It increases insulin sensitivity and reduces pancreatic α- and β-cell death in db/db diabetic mice.{46674} Eleutheroside E (10 and 50 mg/kg) increases the latency to enter the dark chamber in a passive avoidance test and the levels of glutathione (GSH) in the hippocampus and decreases errors in the Y-maze test and hippocampal malondialdehyde (MDA) levels in a mouse model of sleep deprivation-induced stress.{46676}
Brand:CaymanSKU:29684 - 50 mgAvailable on backorder
Eleutheroside E is a glycoside and major component of E. senticosus and has diverse biological activities.{46673} It protects against axonal and dendritic atrophies induced by amyloid-β (25-35) (Aβ (25-35); Item No. 24155) in primary rat cortical neurons.{46673,46675,46674,46676} Eleutheroside E (15, 30, and 60 mg/kg) reduces macrophage infiltration, pannus formation, cartilage damage, bone erosion, and the production of TNF-α and IL-6 in a mouse model of collagen-induced arthritis.{46675} It increases insulin sensitivity and reduces pancreatic α- and β-cell death in db/db diabetic mice.{46674} Eleutheroside E (10 and 50 mg/kg) increases the latency to enter the dark chamber in a passive avoidance test and the levels of glutathione (GSH) in the hippocampus and decreases errors in the Y-maze test and hippocampal malondialdehyde (MDA) levels in a mouse model of sleep deprivation-induced stress.{46676}
Brand:CaymanSKU:29684 - 500 mgAvailable on backorder
Eliglustat is an inhibitor of glucosylceramide synthase (IC50 = 40 nM for inhibition of glucosylceramide production in K562 cells).{41053} It is selective for glucosylceramide synthase over α-glucosidase I and II, α-1,6-glucosidase, lysosomal glucocerebrosidase, non-lysosomal glucosylceramidase, sucrase, and maltase (IC50s = >10 µM for all). It decreases cell surface levels of the gangliosides GM1 and GM3 in K562 and B16/F10 cells with IC50 values of 24 and 29 nM, respectively. Eliglustat (150 mg/kg per day) decreases glucosylceramide levels in the liver and lungs of D409V/null mice, a model of Gaucher disease. Formulations containing eliglustat have been used in the treatment of type 1 Gaucher disease.
Brand:CaymanSKU:21487 -Out of stock
Eliglustat is an inhibitor of glucosylceramide synthase (IC50 = 40 nM for inhibition of glucosylceramide production in K562 cells).{41053} It is selective for glucosylceramide synthase over α-glucosidase I and II, α-1,6-glucosidase, lysosomal glucocerebrosidase, non-lysosomal glucosylceramidase, sucrase, and maltase (IC50s = >10 µM for all). It decreases cell surface levels of the gangliosides GM1 and GM3 in K562 and B16/F10 cells with IC50 values of 24 and 29 nM, respectively. Eliglustat (150 mg/kg per day) decreases glucosylceramide levels in the liver and lungs of D409V/null mice, a model of Gaucher disease. Formulations containing eliglustat have been used in the treatment of type 1 Gaucher disease.
Brand:CaymanSKU:21487 -Out of stock
Eliglustat is an inhibitor of glucosylceramide synthase (IC50 = 40 nM for inhibition of glucosylceramide production in K562 cells).{41053} It is selective for glucosylceramide synthase over α-glucosidase I and II, α-1,6-glucosidase, lysosomal glucocerebrosidase, non-lysosomal glucosylceramidase, sucrase, and maltase (IC50s = >10 µM for all). It decreases cell surface levels of the gangliosides GM1 and GM3 in K562 and B16/F10 cells with IC50 values of 24 and 29 nM, respectively. Eliglustat (150 mg/kg per day) decreases glucosylceramide levels in the liver and lungs of D409V/null mice, a model of Gaucher disease. Formulations containing eliglustat have been used in the treatment of type 1 Gaucher disease.
Brand:CaymanSKU:21487 -Out of stock
Eliglustat is an inhibitor of glucosylceramide synthase (IC50 = 40 nM for inhibition of glucosylceramide production in K562 cells).{41053} It is selective for glucosylceramide synthase over α-glucosidase I and II, α-1,6-glucosidase, lysosomal glucocerebrosidase, non-lysosomal glucosylceramidase, sucrase, and maltase (IC50s = >10 µM for all). It decreases cell surface levels of the gangliosides GM1 and GM3 in K562 and B16/F10 cells with IC50 values of 24 and 29 nM, respectively. Eliglustat (150 mg/kg per day) decreases glucosylceramide levels in the liver and lungs of D409V/null mice, a model of Gaucher disease. Formulations containing eliglustat have been used in the treatment of type 1 Gaucher disease.
Brand:CaymanSKU:21487 -Out of stock
Eliglustat-d15 is intended for use as an internal standard for the quantification of eliglustat (Item No. 21487) by GC- or LC-MS. Eliglustat is an inhibitor of glucosylceramide synthase (IC50 = 40 nM for inhibition of glucosylceramide production in K562 cells).{41053} It is selective for glucosylceramide synthase over α-glucosidase I and II, α-1,6-glucosidase, lysosomal glucocerebrosidase, non-lysosomal glucosylceramidase, sucrase, and maltase (IC50s = >10 µM for all). It decreases cell surface levels of the gangliosides GM1 and GM3 in K562 and B16/F10 cells with IC50 values of 24 and 29 nM, respectively. Eliglustat (150 mg/kg per day) decreases glucosylceramide levels in the liver and lungs of D409V/null mice, a model of Gaucher disease. Formulations containing eliglustat have been used in the treatment of type 1 Gaucher disease.
Brand:CaymanSKU:30167 - 1 mgAvailable on backorder
Eliglustat-d15 is intended for use as an internal standard for the quantification of eliglustat (Item No. 21487) by GC- or LC-MS. Eliglustat is an inhibitor of glucosylceramide synthase (IC50 = 40 nM for inhibition of glucosylceramide production in K562 cells).{41053} It is selective for glucosylceramide synthase over α-glucosidase I and II, α-1,6-glucosidase, lysosomal glucocerebrosidase, non-lysosomal glucosylceramidase, sucrase, and maltase (IC50s = >10 µM for all). It decreases cell surface levels of the gangliosides GM1 and GM3 in K562 and B16/F10 cells with IC50 values of 24 and 29 nM, respectively. Eliglustat (150 mg/kg per day) decreases glucosylceramide levels in the liver and lungs of D409V/null mice, a model of Gaucher disease. Formulations containing eliglustat have been used in the treatment of type 1 Gaucher disease.
Brand:CaymanSKU:30167 - 5 mgAvailable on backorder
Elinogrel is a reversible antagonist of the platelet purinergic P2Y12 receptor (Ki = 23 nM) that inhibits platelet aggregation in a human platelet-rich plasma (hPRP) assay (IC50 = 2.81 nM).{25099} It inhibits thrombosis in a mouse model of vascular injury induced by iron (III) chloride (FeCl3) when administered at a dose of 60 mg/kg.{45029}
Brand:CaymanSKU:25976 - 1 mgAvailable on backorder
Elinogrel is a reversible antagonist of the platelet purinergic P2Y12 receptor (Ki = 23 nM) that inhibits platelet aggregation in a human platelet-rich plasma (hPRP) assay (IC50 = 2.81 nM).{25099} It inhibits thrombosis in a mouse model of vascular injury induced by iron (III) chloride (FeCl3) when administered at a dose of 60 mg/kg.{45029}
Brand:CaymanSKU:25976 - 5 mgAvailable on backorder
N-Methyl-D-aspartate (NMDA) receptors are calcium permeable ligand-gated channels of the central nervous system that are activated after binding of the co-agonists glutamate and glycine. Eliprodil is a non-competitive NMDA receptor antagonist that inhibits neuronal calcium channel currents.{31071} It is selective for NR2B subunit-containing receptors (IC50 = 1 µM), displaying greater than 100-fold selectivity for NR2B over NR2A and NR2C subunits.{31074,31072} Eliprodil also avidly binds σ1 and σ2 sites (Kis = 0.013 and 0.63 µM, respectively).{31074} It is effective in vivo, blocking ischemia-induced neurodegeneration in the CA1 region of the hippocampus of gerbils subjected to bilateral carotid artery occlusion.{31071} Eliprodil can also have proarrhythmic actions in hearts under normal conditions.{31073}
Brand:CaymanSKU:-Available on backorder
N-Methyl-D-aspartate (NMDA) receptors are calcium permeable ligand-gated channels of the central nervous system that are activated after binding of the co-agonists glutamate and glycine. Eliprodil is a non-competitive NMDA receptor antagonist that inhibits neuronal calcium channel currents.{31071} It is selective for NR2B subunit-containing receptors (IC50 = 1 µM), displaying greater than 100-fold selectivity for NR2B over NR2A and NR2C subunits.{31074,31072} Eliprodil also avidly binds σ1 and σ2 sites (Kis = 0.013 and 0.63 µM, respectively).{31074} It is effective in vivo, blocking ischemia-induced neurodegeneration in the CA1 region of the hippocampus of gerbils subjected to bilateral carotid artery occlusion.{31071} Eliprodil can also have proarrhythmic actions in hearts under normal conditions.{31073}
Brand:CaymanSKU:-Available on backorder
N-Methyl-D-aspartate (NMDA) receptors are calcium permeable ligand-gated channels of the central nervous system that are activated after binding of the co-agonists glutamate and glycine. Eliprodil is a non-competitive NMDA receptor antagonist that inhibits neuronal calcium channel currents.{31071} It is selective for NR2B subunit-containing receptors (IC50 = 1 µM), displaying greater than 100-fold selectivity for NR2B over NR2A and NR2C subunits.{31074,31072} Eliprodil also avidly binds σ1 and σ2 sites (Kis = 0.013 and 0.63 µM, respectively).{31074} It is effective in vivo, blocking ischemia-induced neurodegeneration in the CA1 region of the hippocampus of gerbils subjected to bilateral carotid artery occlusion.{31071} Eliprodil can also have proarrhythmic actions in hearts under normal conditions.{31073}
Brand:CaymanSKU:-Available on backorder
N-Methyl-D-aspartate (NMDA) receptors are calcium permeable ligand-gated channels of the central nervous system that are activated after binding of the co-agonists glutamate and glycine. Eliprodil is a non-competitive NMDA receptor antagonist that inhibits neuronal calcium channel currents.{31071} It is selective for NR2B subunit-containing receptors (IC50 = 1 µM), displaying greater than 100-fold selectivity for NR2B over NR2A and NR2C subunits.{31074,31072} Eliprodil also avidly binds σ1 and σ2 sites (Kis = 0.013 and 0.63 µM, respectively).{31074} It is effective in vivo, blocking ischemia-induced neurodegeneration in the CA1 region of the hippocampus of gerbils subjected to bilateral carotid artery occlusion.{31071} Eliprodil can also have proarrhythmic actions in hearts under normal conditions.{31073}
Brand:CaymanSKU:-Available on backorder
Ellagic acid is a polyphenolic antioxidant that is abundant in many fruits, vegetables, plant bark, and peels. It has anti-carcinogenic, anti-mutagenic, anti-inflammatory, and organ-preserving properties, presumably related to its ability to alter cytochrome P450 activity and improve metabolism and clearance of xenobiotics, as well as alter immune function.{18587,18585,18586} Ellagic acid also blocks methylation of arginine 17 of histone 3 (H3R17) by coactivator-associated arginine methyltransferase 1 (CARM1) without significantly altering histone acetylase or DNA methyltransferase activity.{18399,18400,18401}
Brand:CaymanSKU:10569 - 1 gAvailable on backorder
Ellagic acid is a polyphenolic antioxidant that is abundant in many fruits, vegetables, plant bark, and peels. It has anti-carcinogenic, anti-mutagenic, anti-inflammatory, and organ-preserving properties, presumably related to its ability to alter cytochrome P450 activity and improve metabolism and clearance of xenobiotics, as well as alter immune function.{18587,18585,18586} Ellagic acid also blocks methylation of arginine 17 of histone 3 (H3R17) by coactivator-associated arginine methyltransferase 1 (CARM1) without significantly altering histone acetylase or DNA methyltransferase activity.{18399,18400,18401}
Brand:CaymanSKU:10569 - 100 mgAvailable on backorder
Ellagic acid is a polyphenolic antioxidant that is abundant in many fruits, vegetables, plant bark, and peels. It has anti-carcinogenic, anti-mutagenic, anti-inflammatory, and organ-preserving properties, presumably related to its ability to alter cytochrome P450 activity and improve metabolism and clearance of xenobiotics, as well as alter immune function.{18587,18585,18586} Ellagic acid also blocks methylation of arginine 17 of histone 3 (H3R17) by coactivator-associated arginine methyltransferase 1 (CARM1) without significantly altering histone acetylase or DNA methyltransferase activity.{18399,18400,18401}
Brand:CaymanSKU:10569 - 500 mgAvailable on backorder
Ellipticine is an alkaloid isolated from Apocyanaceae plants that exhibits antitumor activities by intercalating into DNA and/or inhibiting DNA topoisomerase II.{30281,30282,30280} It forms covalent adducts in DNA after being enzymatically activated with cytochrome P450 isoforms (e.g., CYP3A4, CYP1A1, or CYP1A2) or by peroxidases in target tissues.{30282,30280} Ellipticine has been shown to inhibit the proliferation of human breast adenocarcinoma MCF-7 cells, leukemia HL-60 and CCRF-CEM cells, neuroblastoma IMR-32, UKF-NB-3, and UKF-NB-4 cells, and U87MG glioblastoma cells with IC50 values ranging from 0.27-4.7 µM.{30282}
Brand:CaymanSKU:-Available on backorder
Ellipticine is an alkaloid isolated from Apocyanaceae plants that exhibits antitumor activities by intercalating into DNA and/or inhibiting DNA topoisomerase II.{30281,30282,30280} It forms covalent adducts in DNA after being enzymatically activated with cytochrome P450 isoforms (e.g., CYP3A4, CYP1A1, or CYP1A2) or by peroxidases in target tissues.{30282,30280} Ellipticine has been shown to inhibit the proliferation of human breast adenocarcinoma MCF-7 cells, leukemia HL-60 and CCRF-CEM cells, neuroblastoma IMR-32, UKF-NB-3, and UKF-NB-4 cells, and U87MG glioblastoma cells with IC50 values ranging from 0.27-4.7 µM.{30282}
Brand:CaymanSKU:-Available on backorder
Ellipticine is an alkaloid isolated from Apocyanaceae plants that exhibits antitumor activities by intercalating into DNA and/or inhibiting DNA topoisomerase II.{30281,30282,30280} It forms covalent adducts in DNA after being enzymatically activated with cytochrome P450 isoforms (e.g., CYP3A4, CYP1A1, or CYP1A2) or by peroxidases in target tissues.{30282,30280} Ellipticine has been shown to inhibit the proliferation of human breast adenocarcinoma MCF-7 cells, leukemia HL-60 and CCRF-CEM cells, neuroblastoma IMR-32, UKF-NB-3, and UKF-NB-4 cells, and U87MG glioblastoma cells with IC50 values ranging from 0.27-4.7 µM.{30282}
Brand:CaymanSKU:-Available on backorder
Ellipticine is an alkaloid isolated from Apocyanaceae plants that exhibits antitumor activities by intercalating into DNA and/or inhibiting DNA topoisomerase II.{30281,30282,30280} It forms covalent adducts in DNA after being enzymatically activated with cytochrome P450 isoforms (e.g., CYP3A4, CYP1A1, or CYP1A2) or by peroxidases in target tissues.{30282,30280} Ellipticine has been shown to inhibit the proliferation of human breast adenocarcinoma MCF-7 cells, leukemia HL-60 and CCRF-CEM cells, neuroblastoma IMR-32, UKF-NB-3, and UKF-NB-4 cells, and U87MG glioblastoma cells with IC50 values ranging from 0.27-4.7 µM.{30282}
Brand:CaymanSKU:-Available on backorder
ELR510444 is an inhibitor of tubulin polymerization (IC50 = 10 μM) that binds to tubulin at the colchicine (Item No. 9000760) binding site.{38488} It induces microtubule depolymerization in A-10 cells (EC50 = 21 nM). ELR510444 inhibits growth in a cancer cell line panel (IC50s = 9-43 nM) via formation of multiple spindles and induction of mitotic arrest. Oral administration of ELR510444 (3-6 mg/kg) reduces tumor size in an MDA-MB-231 breast cancer mouse xenograft model in a dose-dependent manner. ELR510444 also inhibits hypoxia-inducible factor 1α (HIF-1α) in RCC4 cells in a concentration-dependent manner.{38487}
Brand:CaymanSKU:-Available on backorder
ELR510444 is an inhibitor of tubulin polymerization (IC50 = 10 μM) that binds to tubulin at the colchicine (Item No. 9000760) binding site.{38488} It induces microtubule depolymerization in A-10 cells (EC50 = 21 nM). ELR510444 inhibits growth in a cancer cell line panel (IC50s = 9-43 nM) via formation of multiple spindles and induction of mitotic arrest. Oral administration of ELR510444 (3-6 mg/kg) reduces tumor size in an MDA-MB-231 breast cancer mouse xenograft model in a dose-dependent manner. ELR510444 also inhibits hypoxia-inducible factor 1α (HIF-1α) in RCC4 cells in a concentration-dependent manner.{38487}
Brand:CaymanSKU:-Available on backorder
ELR510444 is an inhibitor of tubulin polymerization (IC50 = 10 μM) that binds to tubulin at the colchicine (Item No. 9000760) binding site.{38488} It induces microtubule depolymerization in A-10 cells (EC50 = 21 nM). ELR510444 inhibits growth in a cancer cell line panel (IC50s = 9-43 nM) via formation of multiple spindles and induction of mitotic arrest. Oral administration of ELR510444 (3-6 mg/kg) reduces tumor size in an MDA-MB-231 breast cancer mouse xenograft model in a dose-dependent manner. ELR510444 also inhibits hypoxia-inducible factor 1α (HIF-1α) in RCC4 cells in a concentration-dependent manner.{38487}
Brand:CaymanSKU:-Available on backorder
ELR510444 is an inhibitor of tubulin polymerization (IC50 = 10 μM) that binds to tubulin at the colchicine (Item No. 9000760) binding site.{38488} It induces microtubule depolymerization in A-10 cells (EC50 = 21 nM). ELR510444 inhibits growth in a cancer cell line panel (IC50s = 9-43 nM) via formation of multiple spindles and induction of mitotic arrest. Oral administration of ELR510444 (3-6 mg/kg) reduces tumor size in an MDA-MB-231 breast cancer mouse xenograft model in a dose-dependent manner. ELR510444 also inhibits hypoxia-inducible factor 1α (HIF-1α) in RCC4 cells in a concentration-dependent manner.{38487}
Brand:CaymanSKU:-Available on backorder
Eltenac is a non-selective COX inhibitor (IC50 = 0.03 µM for both COX-1 and COX-2 in isolated human whole blood) and a non-steroidal anti-inflammatory drug (NSAID).{55033} In vivo, eltenac (1 mg/kg) reduces lameness in horses with tendinitis, pododermatitis, navicular disease, non-infectious arthritis, degenerative joint disease, phalanx fracture, and osteochondrosis.{55034} It also reduces castration-induced edema in horses. Formulations containing eltenac have been used in the treatment of postoperative swelling in horses.
Brand:CaymanSKU:27673 - 1 mgAvailable on backorder
Eltenac is a non-selective COX inhibitor (IC50 = 0.03 µM for both COX-1 and COX-2 in isolated human whole blood) and a non-steroidal anti-inflammatory drug (NSAID).{55033} In vivo, eltenac (1 mg/kg) reduces lameness in horses with tendinitis, pododermatitis, navicular disease, non-infectious arthritis, degenerative joint disease, phalanx fracture, and osteochondrosis.{55034} It also reduces castration-induced edema in horses. Formulations containing eltenac have been used in the treatment of postoperative swelling in horses.
Brand:CaymanSKU:27673 - 5 mgAvailable on backorder
Eltenac is a non-selective COX inhibitor (IC50 = 0.03 µM for both COX-1 and COX-2 in isolated human whole blood) and a non-steroidal anti-inflammatory drug (NSAID).{55033} In vivo, eltenac (1 mg/kg) reduces lameness in horses with tendinitis, pododermatitis, navicular disease, non-infectious arthritis, degenerative joint disease, phalanx fracture, and osteochondrosis.{55034} It also reduces castration-induced edema in horses. Formulations containing eltenac have been used in the treatment of postoperative swelling in horses.
Brand:CaymanSKU:27673 - 500 µgAvailable on backorder
Eltoprazine is a phenylpiperazine compound that acts as a partial agonist at serotonin 5-HT1A, 5-HT1B, and 5-HT2B receptors (Kis = 40, 52, and 81 nM, respectively).{29966} It exerts a dose-dependent decrease in aggressive behavior in resident-intruder tests with rats (ID50 = 0.24 mg/kg).{29965}
Brand:CaymanSKU:-Available on backorder
Eltoprazine is a phenylpiperazine compound that acts as a partial agonist at serotonin 5-HT1A, 5-HT1B, and 5-HT2B receptors (Kis = 40, 52, and 81 nM, respectively).{29966} It exerts a dose-dependent decrease in aggressive behavior in resident-intruder tests with rats (ID50 = 0.24 mg/kg).{29965}
Brand:CaymanSKU:-Available on backorder
Eltoprazine is a phenylpiperazine compound that acts as a partial agonist at serotonin 5-HT1A, 5-HT1B, and 5-HT2B receptors (Kis = 40, 52, and 81 nM, respectively).{29966} It exerts a dose-dependent decrease in aggressive behavior in resident-intruder tests with rats (ID50 = 0.24 mg/kg).{29965}
Brand:CaymanSKU:-Available on backorder
Eltoprazine is a phenylpiperazine compound that acts as a partial agonist at serotonin 5-HT1A, 5-HT1B, and 5-HT2B receptors (Kis = 40, 52, and 81 nM, respectively).{29966} It exerts a dose-dependent decrease in aggressive behavior in resident-intruder tests with rats (ID50 = 0.24 mg/kg).{29965}
Brand:CaymanSKU:-Available on backorder
Eltrombopag is an orally bioavailable nonpeptide agonist of the thrombopoietin receptor (EC50 = 0.27 µM in a reporter assay) and an iron chelator.{16951} It increases STAT5 phosphorylation in N2C-Tpo cells when used at a concentration of 30 µM and p42/44 MAPK phosphorylation when used at 10 µM. Eltrombopag binds to the transmembrane domain of the thrombopoietin receptor and stimulates megakaryocytopoiesis in human primary bone marrow cells. It increases platelet production in chimpanzees when administered at a dose of 10 mg/kg per day for five days. Eltrombopag also binds to iron (III) and mobilizes cellular iron and ferritin in H9C2, Huh7, and RINm5F cells in a concentration-dependent manner.{47035} It enhances cellular iron mobilization when used in combination with the iron chelators deferasirox (Item No. 16753) and CP40.
Brand:CaymanSKU:- Eltrombopag is an orally bioavailable nonpeptide agonist of the thrombopoietin receptor (EC50 = 0.27 µM in a reporter assay) and an iron chelator.{16951} It increases STAT5 phosphorylation in N2C-Tpo cells when used at a concentration of 30 µM and p42/44 MAPK phosphorylation when used at 10 µM. Eltrombopag binds to the transmembrane domain of the thrombopoietin receptor and stimulates megakaryocytopoiesis in human primary bone marrow cells. It increases platelet production in chimpanzees when administered at a dose of 10 mg/kg per day for five days. Eltrombopag also binds to iron (III) and mobilizes cellular iron and ferritin in H9C2, Huh7, and RINm5F cells in a concentration-dependent manner.{47035} It enhances cellular iron mobilization when used in combination with the iron chelators deferasirox (Item No. 16753) and CP40.
Brand:CaymanSKU:- Eltrombopag is an orally bioavailable nonpeptide agonist of the thrombopoietin receptor (EC50 = 0.27 µM in a reporter assay) and an iron chelator.{16951} It increases STAT5 phosphorylation in N2C-Tpo cells when used at a concentration of 30 µM and p42/44 MAPK phosphorylation when used at 10 µM. Eltrombopag binds to the transmembrane domain of the thrombopoietin receptor and stimulates megakaryocytopoiesis in human primary bone marrow cells. It increases platelet production in chimpanzees when administered at a dose of 10 mg/kg per day for five days. Eltrombopag also binds to iron (III) and mobilizes cellular iron and ferritin in H9C2, Huh7, and RINm5F cells in a concentration-dependent manner.{47035} It enhances cellular iron mobilization when used in combination with the iron chelators deferasirox (Item No. 16753) and CP40.
Brand:CaymanSKU:- Eltrombopag is an orally bioavailable nonpeptide agonist of the thrombopoietin receptor (EC50 = 0.27 µM in a reporter assay) and an iron chelator.{16951} It increases STAT5 phosphorylation in N2C-Tpo cells when used at a concentration of 30 µM and p42/44 MAPK phosphorylation when used at 10 µM. Eltrombopag binds to the transmembrane domain of the thrombopoietin receptor and stimulates megakaryocytopoiesis in human primary bone marrow cells. It increases platelet production in chimpanzees when administered at a dose of 10 mg/kg per day for five days. Eltrombopag also binds to iron (III) and mobilizes cellular iron and ferritin in H9C2, Huh7, and RINm5F cells in a concentration-dependent manner.{47035} It enhances cellular iron mobilization when used in combination with the iron chelators deferasirox (Item No. 16753) and CP40.
Brand:CaymanSKU:-
Elvitegravir is a quinolone antibiotic that inhibits HIV-1 integrase (IC50 = 7.2 nM).{29011} It has antiviral activity against laboratory strains and clinical isolates of HIV-1 in MAGI cells (EC50s = 0.1-1.26 nM) and HIV-2 in peripheral blood mononuclear cells (PBMCs; EC50s = 0.3-0.9).{20011,42943} Formulations containing elvitegravir have been used in the treatment of HIV infections.
Brand:CaymanSKU:-Available on backorder
Elvitegravir is a quinolone antibiotic that inhibits HIV-1 integrase (IC50 = 7.2 nM).{29011} It has antiviral activity against laboratory strains and clinical isolates of HIV-1 in MAGI cells (EC50s = 0.1-1.26 nM) and HIV-2 in peripheral blood mononuclear cells (PBMCs; EC50s = 0.3-0.9).{20011,42943} Formulations containing elvitegravir have been used in the treatment of HIV infections.
Brand:CaymanSKU:-Available on backorder
Elvitegravir is a quinolone antibiotic that inhibits HIV-1 integrase (IC50 = 7.2 nM).{29011} It has antiviral activity against laboratory strains and clinical isolates of HIV-1 in MAGI cells (EC50s = 0.1-1.26 nM) and HIV-2 in peripheral blood mononuclear cells (PBMCs; EC50s = 0.3-0.9).{20011,42943} Formulations containing elvitegravir have been used in the treatment of HIV infections.
Brand:CaymanSKU:-Available on backorder
Elvitegravir is a quinolone antibiotic that inhibits HIV-1 integrase (IC50 = 7.2 nM).{29011} It has antiviral activity against laboratory strains and clinical isolates of HIV-1 in MAGI cells (EC50s = 0.1-1.26 nM) and HIV-2 in peripheral blood mononuclear cells (PBMCs; EC50s = 0.3-0.9).{20011,42943} Formulations containing elvitegravir have been used in the treatment of HIV infections.
Brand:CaymanSKU:-Available on backorder
EM574 is a motilin receptor agonist with an IC50 value of 6.17 nM for binding to rabbit gastric antral smooth muscle homogenates in a radioligand binding assay.{45198} It also binds to human smooth muscle homogenates in a radioligand binding assay (Kd = 7.8 nM).{45199} EM574 induces contraction of isolated rabbit, but not rat or guinea pig, intestine (EC50 = 5.5 nM).{45198} It increases antral motility and enhances gastric emptying in canine models of gastroparesis when administered intraduodenally at a dose of 0.03 mg/kg following a semi-solid meal.{45200}
Brand:CaymanSKU:27752 - 1 mgAvailable on backorder
EM574 is a motilin receptor agonist with an IC50 value of 6.17 nM for binding to rabbit gastric antral smooth muscle homogenates in a radioligand binding assay.{45198} It also binds to human smooth muscle homogenates in a radioligand binding assay (Kd = 7.8 nM).{45199} EM574 induces contraction of isolated rabbit, but not rat or guinea pig, intestine (EC50 = 5.5 nM).{45198} It increases antral motility and enhances gastric emptying in canine models of gastroparesis when administered intraduodenally at a dose of 0.03 mg/kg following a semi-solid meal.{45200}
Brand:CaymanSKU:27752 - 500 µgAvailable on backorder
EMA401 is an orally bioavailable and selective antagonist of the angiotensin II type 2 receptor (AT2; IC50s = 39.5 and 408,000 nM for rat recombinant AT2 and AT1, respectively).{47001} It inhibits capsaicin-induced calcium influx in cultured human dorsal root ganglion (hDRG) neurons (IC50 = 10 nM) and reduces neurite density and length in rat DRG neuronal cultures.{47002} EMA401 has analgesic effects in a rat model of neuropathic pain induced by chronic constriction injury.{47003}
Brand:CaymanSKU:22988 - 1 mgAvailable on backorder
EMA401 is an orally bioavailable and selective antagonist of the angiotensin II type 2 receptor (AT2; IC50s = 39.5 and 408,000 nM for rat recombinant AT2 and AT1, respectively).{47001} It inhibits capsaicin-induced calcium influx in cultured human dorsal root ganglion (hDRG) neurons (IC50 = 10 nM) and reduces neurite density and length in rat DRG neuronal cultures.{47002} EMA401 has analgesic effects in a rat model of neuropathic pain induced by chronic constriction injury.{47003}
Brand:CaymanSKU:22988 - 10 mgAvailable on backorder
EMA401 is an orally bioavailable and selective antagonist of the angiotensin II type 2 receptor (AT2; IC50s = 39.5 and 408,000 nM for rat recombinant AT2 and AT1, respectively).{47001} It inhibits capsaicin-induced calcium influx in cultured human dorsal root ganglion (hDRG) neurons (IC50 = 10 nM) and reduces neurite density and length in rat DRG neuronal cultures.{47002} EMA401 has analgesic effects in a rat model of neuropathic pain induced by chronic constriction injury.{47003}
Brand:CaymanSKU:22988 - 25 mgAvailable on backorder
EMA401 is an orally bioavailable and selective antagonist of the angiotensin II type 2 receptor (AT2; IC50s = 39.5 and 408,000 nM for rat recombinant AT2 and AT1, respectively).{47001} It inhibits capsaicin-induced calcium influx in cultured human dorsal root ganglion (hDRG) neurons (IC50 = 10 nM) and reduces neurite density and length in rat DRG neuronal cultures.{47002} EMA401 has analgesic effects in a rat model of neuropathic pain induced by chronic constriction injury.{47003}
Brand:CaymanSKU:22988 - 5 mgAvailable on backorder
Emamectin B1a is a semi-synthetic derivative of avermectin B1a (Item No. 22000).{35148} It binds to GABAA receptors (Ki = 17.6 nM in rat brain membranes), including those containing β1, β2, or β3 subunits (IC50s = 57, 210, and 49.8 nM for α1β1γ2, α1β2γ2, and α1β3γ2 subunits, respectively), and potentiates the GABA response.{35146} Emamectin B1a also binds to and inhibits glycine receptors (IC50 = 218 nM in rat spinal cord). Emamectin B1a induces mortality in 90% of S. exigua larvae in a diet incorporation assay at a dose of 1.067 ng/ml, which is approximately 1,500-fold more toxic than avermectin B1. It is effective against neonate S. eridania larvae in a foliage spray bioassay and when applied topically.
Brand:CaymanSKU:24060 - 1 mgAvailable on backorder